{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:59:22Z","timestamp":1793829562051,"version":"4.6.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100008323","name":"Zanjan University of Medical Sciences","doi-asserted-by":"publisher","award":["Grant Number: A-12-1244-22 & Ethical Code: IR.ZUMS.REC.1400.518"],"award-info":[{"award-number":["Grant Number: A-12-1244-22 & Ethical Code: IR.ZUMS.REC.1400.518"]}],"id":[{"id":"10.13039\/501100008323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05074-1","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T23:01:36Z","timestamp":1751410896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Combined treatment using bismuth sulfide nanoparticles loaded with NANOG decoy oligodeoxynucleotides under X-ray radiation for breast cancer cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Sara","family":"Heidari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Gharbavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roghayeh","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Rezaeejam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrooz","family":"Johari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"20","key":"5074_CR1","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1038\/onc.2013.209","volume":"33","author":"X Lu","year":"2014","unstructured":"Lu, X., Mazur, S. J., Lin, T., Appella, E. & Xu, Y. The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. Oncogene 33(20), 2655\u20132664 (2014).","journal-title":"Oncogene"},{"issue":"1","key":"5074_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.canlet.2012.02.021","volume":"321","author":"J Han","year":"2012","unstructured":"Han, J. et al. RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0\/G1 cell cycle arrest in breast cancer cells. Cancer Lett. 321(1), 80\u201388 (2012).","journal-title":"Cancer Lett."},{"issue":"11","key":"5074_CR3","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1002\/jcp.24076","volume":"227","author":"SC Choi","year":"2012","unstructured":"Choi, S. C. et al. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells. J. Cell. Physiol. 227(11), 3678\u20133692 (2012).","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"5074_CR4","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.7150\/ijbs.21635","volume":"13","author":"Y-S Sun","year":"2017","unstructured":"Sun, Y.-S. et al. Risk factors and preventions of breast cancer. Int. J. Biol. Sci. 13(11), 1387 (2017).","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"5074_CR5","doi-asserted-by":"publisher","first-page":"1901695","DOI":"10.1002\/adhm.201901695","volume":"9","author":"S Badrigilan","year":"2020","unstructured":"Badrigilan, S. et al. Bismuth-based nanomaterials: Recent advances in tumor targeting and synergistic cancer therapy techniques. Adv. Healthc. Mater. 9(7), 1901695 (2020).","journal-title":"Adv. Healthc. Mater."},{"key":"5074_CR6","doi-asserted-by":"publisher","first-page":"119320","DOI":"10.1016\/j.ijpharm.2020.119320","volume":"582","author":"MH Faghfoori","year":"2020","unstructured":"Faghfoori, M. H. et al. Anticancer effect of X-Ray triggered methotrexate conjugated albumin coated bismuth sulfide nanoparticles on SW480 colon cancer cell line. Int. J. Pharm. 582, 119320 (2020).","journal-title":"Int. J. Pharm."},{"issue":"13","key":"5074_CR7","first-page":"1786","volume":"17","author":"B Johari","year":"2017","unstructured":"Johari, B. et al. Myc decoy oligodeoxynucleotide inhibits growth and modulates differentiation of mouse embryonic stem cells as a model of cancer stem cells. Anti Cancer Agents Med. Chem. 17(13), 1786\u20131795 (2017).","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"5074_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/12_2011_139","volume-title":"Nucleic Acid Drugs","author":"MK Osako","year":"2011","unstructured":"Osako, M. K., Nakagami, H. & Morishita, R. Development and modification of decoy oligodeoxynucleotides for clinical application. In Nucleic Acid Drugs 49\u201359 (Springer, 2011)."},{"issue":"2","key":"5074_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.32604\/or.2023.043576","volume":"32","author":"B Johari","year":"2023","unstructured":"Johari, B. et al. Combinational therapy with Myc decoy oligodeoxynucleotides encapsulated in nanocarrier and X-irradiation on breast cancer cells. Oncol. Res. 32(2), 309 (2023).","journal-title":"Oncol. Res."},{"issue":"1","key":"5074_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.32604\/or.2023.044741","volume":"32","author":"R Ghorbani","year":"2023","unstructured":"Ghorbani, R. et al. Targeted anti-tumor synergistic effects of Myc decoy oligodeoxynucleotides-loaded selenium nanostructure combined with chemoradiotherapy on LNCaP prostate cancer cells. Oncol. Res. 32(1), 101 (2023).","journal-title":"Oncol. Res."},{"issue":"1","key":"5074_CR11","first-page":"15","volume":"4","author":"M Babaei","year":"2014","unstructured":"Babaei, M. & Ganjalikhani, M. The potential effectiveness of nanoparticles as radio sensitizers for radiotherapy. Bioimpacts 4(1), 15 (2014).","journal-title":"Bioimpacts"},{"issue":"11","key":"5074_CR12","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1248\/cpb.58.1423","volume":"58","author":"K Nagpal","year":"2010","unstructured":"Nagpal, K., Singh, S. K. & Mishra, D. N. Chitosan nanoparticles: A promising system in novel drug delivery. Chem. Pharm. Bull. 58(11), 1423\u20131430 (2010).","journal-title":"Chem. Pharm. Bull."},{"key":"5074_CR13","doi-asserted-by":"publisher","first-page":"6793","DOI":"10.1007\/s11033-020-05737-4","volume":"47","author":"B Johari","year":"2020","unstructured":"Johari, B. et al. Increasing the colon cancer cells sensitivity toward radiation therapy via application of Oct4\u2013Sox2 complex decoy oligodeoxynucleotides. Mol. Biol. Rep. 47, 6793\u20136805 (2020).","journal-title":"Mol. Biol. Rep."},{"issue":"13","key":"5074_CR14","doi-asserted-by":"publisher","first-page":"e34096","DOI":"10.1016\/j.heliyon.2024.e34096","volume":"10","author":"B Johari","year":"2024","unstructured":"Johari, B. et al. Suppress the cell growth of cancer stem-like cells (NTERA-2) using Sox2-Oct4 decoy oligodeoxynucleotide\u2014encapsulated niosomes-zinc hybrid nanocarriers under X-irradiation. Heliyon 10(13), e34096 (2024).","journal-title":"Heliyon"},{"issue":"24","key":"5074_CR15","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1021\/acschemneuro.0c00699","volume":"11","author":"M Gharbavi","year":"2020","unstructured":"Gharbavi, M. et al. NANOG decoy oligodeoxynucleotide\u2013encapsulated niosomes nanocarriers: A promising approach to suppress the metastatic properties of U87 human glioblastoma multiforme cells. ACS Chem. Neurosci. 11(24), 4499\u20134515 (2020).","journal-title":"ACS Chem. Neurosci."},{"issue":"6","key":"5074_CR16","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cell.2008.04.043","volume":"133","author":"X Chen","year":"2008","unstructured":"Chen, X. et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133(6), 1106\u20131117 (2008).","journal-title":"Cell"},{"issue":"6","key":"5074_CR17","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1002\/jcp.29431","volume":"235","author":"M Rahmati","year":"2020","unstructured":"Rahmati, M., Johari, B., Kadivar, M., Rismani, E. & Mortazavi, Y. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy. J. Cell. Physiol. 235(6), 5429\u20135444 (2020).","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"5074_CR18","doi-asserted-by":"publisher","first-page":"e7327","DOI":"10.1002\/aoc.7327","volume":"38","author":"M Gharbavi","year":"2024","unstructured":"Gharbavi, M., Johari, B., Tabar, R. M. & Sharafi, A. Selenium-doped albumin nanoparticles enhance tamoxifen-induced anticancer effects in 4T\u20131 mouse breast cancer cells. Appl. Organomet. Chem. 38(2), e7327 (2024).","journal-title":"Appl. Organomet. Chem."},{"key":"5074_CR19","doi-asserted-by":"publisher","first-page":"124285","DOI":"10.1016\/j.ijpharm.2024.124285","volume":"659","author":"N Asadi","year":"2024","unstructured":"Asadi, N., Gharbavi, M., Rezaeejam, H., Farajollahi, A. & Johari, B. Zinc nanoparticles coated with doxorubicin-conjugated alginate as a radiation sensitizer in triple-negative breast cancer cells. Int. J. Pharm. 659, 124285 (2024).","journal-title":"Int. J. Pharm."},{"issue":"1","key":"5074_CR20","first-page":"4825472","volume":"2022","author":"B Jafari","year":"2022","unstructured":"Jafari, B. et al. Mitigated oxidative stress and cognitive impairments in transient global ischemia using niosomal selegiline-NBP delivery. Behav. Neurol. 2022(1), 4825472 (2022).","journal-title":"Behav. Neurol."},{"issue":"1","key":"5074_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s11033-024-09559-6","volume":"51","author":"R Ghorbani","year":"2024","unstructured":"Ghorbani, R., Gharbavi, M., Keshavarz, B., Madanchi, H. & Johari, B. Targeting c-Myc with decoy oligodeoxynucleotide-loaded polycationic nanoparticles inhibits cell growth and induces apoptosis in cancer stem-like cells (NTERA-2). Mol. Biol. Rep. 51(1), 623 (2024).","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"5074_CR22","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s42250-022-00425-1","volume":"5","author":"H Felenji","year":"2022","unstructured":"Felenji, H., Johari, B., Moradi, M., Gharbavi, M. & Danafar, H. Folic acid-conjugated iron oxide magnetic nanoparticles based on bovine serum albumin (BSA) for targeted delivery of curcumin to suppress liver cancer cells. Chem. Afr. 5(5), 1627\u20131639 (2022).","journal-title":"Chem. Afr."},{"issue":"12","key":"5074_CR23","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/cbin.11456","volume":"44","author":"B Johari","year":"2020","unstructured":"Johari, B. et al. Evaluation of STAT3 decoy oligodeoxynucleotides\u2019 synergistic effects on radiation and\/or chemotherapy in metastatic breast cancer cell line. Cell Biol. Int. 44(12), 2499\u20132511 (2020).","journal-title":"Cell Biol. Int."},{"issue":"1","key":"5074_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin. 69(1), 7\u201334 (2019).","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"5074_CR25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/21691401.2017.1326928","volume":"46","author":"SE Yazdi Rouholamini","year":"2018","unstructured":"Yazdi Rouholamini, S. E. et al. Effect of silibinin-loaded nano-niosomal coated with trimethyl chitosan on miRNAs expression in 2D and 3D models of T47D breast cancer cell line. Artif. Cells Nanomed. Biotechnol. 46(3), 524\u2013535 (2018).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"14","key":"5074_CR26","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.7314\/APJCP.2015.16.14.5977","volume":"16","author":"S Hajighasemlou","year":"2015","unstructured":"Hajighasemlou, S. et al. Preparation of immunotoxin herceptin-botulinum and killing effects on two breast cancer cell lines. Asian Pac. J. Cancer Prev. 16(14), 5977\u20135981 (2015).","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"19","key":"5074_CR27","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.3390\/polym14194131","volume":"14","author":"N Rasouli","year":"2022","unstructured":"Rasouli, N. et al. Assessment of oxaliplatin-loaded iodine nanoparticles for chemoradiotherapy of human colorectal cancer (HT-29) cells. Polymers 14(19), 4131 (2022).","journal-title":"Polymers"},{"issue":"23","key":"5074_CR28","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1002\/adma.201103289","volume":"42","author":"K Ai","year":"2011","unstructured":"Ai, K. et al. Large-scale synthesis of Bi2S3 nanodots as a contrast agent for in vivo X-ray computed tomography imaging. Adv. Mater. 42(23), 4886\u20134891 (2011).","journal-title":"Adv. Mater."},{"issue":"51","key":"5074_CR29","doi-asserted-by":"publisher","first-page":"12308","DOI":"10.1002\/anie.201104507","volume":"50","author":"JM Kinsella","year":"2011","unstructured":"Kinsella, J. M. et al. X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew. Chem. Int. Ed. 50(51), 12308\u201312311 (2011).","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"5074_CR30","doi-asserted-by":"publisher","first-page":"e0192443","DOI":"10.1371\/journal.pone.0192443","volume":"13","author":"M Glatz","year":"2018","unstructured":"Glatz, M. et al. Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis. PLoS ONE 13(2), e0192443 (2018).","journal-title":"PLoS ONE"},{"issue":"8","key":"5074_CR31","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3390\/nano10081463","volume":"10","author":"JC Bulmahn","year":"2020","unstructured":"Bulmahn, J. C. et al. Laser-ablative synthesis of stable aqueous solutions of elemental bismuth nanoparticles for multimodal theranostic applications. Nanomaterials 10(8), 1463 (2020).","journal-title":"Nanomaterials"},{"issue":"9","key":"5074_CR32","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1021\/acsbiomaterials.9b00489","volume":"5","author":"H Nosrati","year":"2019","unstructured":"Nosrati, H., Charmi, J., Salehiabar, M., Abhari, F. & Danafar, H. Tumor targeted albumin coated bismuth sulfide nanoparticles (Bi2S3) as radiosensitizers and carriers of curcumin for enhanced chemoradiation therapy. ACS Biomater. Sci. Eng. 5(9), 4416\u20134424 (2019).","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"1","key":"5074_CR33","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1080\/21691401.2019.1669624","volume":"47","author":"H Nosrati","year":"2019","unstructured":"Nosrati, H. et al. Facile green synthesis of bismuth sulfide radiosensitizer via biomineralization of albumin natural molecule for chemoradiation therapy aim. Artif Cells Nanomed. Biotechnol. 47(1), 3832\u20133838 (2019).","journal-title":"Artif Cells Nanomed. Biotechnol."},{"key":"5074_CR34","unstructured":"Lee, C. High-Z metal encapsulated carbon dots for enhancing radiation therapy. University of Georgia (2020)."},{"issue":"1","key":"5074_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.lwt.2010.06.032","volume":"44","author":"Y Byun","year":"2011","unstructured":"Byun, Y. et al. Formulation and characterization of \u03b1-tocopherol loaded poly \u025b-caprolactone (PCL) nanoparticles. LWT Food Sci. Technol. 44(1), 24\u201328 (2011).","journal-title":"LWT Food Sci. Technol."},{"issue":"1","key":"5074_CR36","doi-asserted-by":"publisher","first-page":"e5251","DOI":"10.1002\/aoc.5251","volume":"34","author":"S Azizi","year":"2020","unstructured":"Azizi, S., Nosrati, H., Sharafi, A. & Danafar, H. Preparation of bismuth sulfide nanoparticles as targeted biocompatible nano-radiosensitizer and carrier of methotrexate. Appl. Organomet. Chem. 34(1), e5251 (2020).","journal-title":"Appl. Organomet. Chem."},{"key":"5074_CR37","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s10856-012-4716-1","volume":"23","author":"Y Luo","year":"2012","unstructured":"Luo, Y. et al. In vitro cytotoxicity of surface modified bismuth nanoparticles. J. Mater. Sci. Mater. Med. 23, 2563\u20132573 (2012).","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"13","key":"5074_CR38","doi-asserted-by":"publisher","first-page":"15718","DOI":"10.1021\/acsami.3c17024","volume":"16","author":"B Colak","year":"2024","unstructured":"Colak, B. & Ertas, Y. N. Implantable, 3D-printed alginate scaffolds with bismuth sulfide nanoparticles for the treatment of local breast cancer via enhanced radiotherapy. ACS Appl. Mater. Interfaces 16(13), 15718\u201315729 (2024).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"5074_CR39","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1007\/s11033-011-0928-6","volume":"39","author":"T Chen","year":"2012","unstructured":"Chen, T., Du, J. & Lu, G. Cell growth arrest and apoptosis induced by Oct4 or Nanog knockdown in mouse embryonic stem cells: a possible role of Trp53. Mol. Biol. Rep. 39, 1855\u20131861 (2012).","journal-title":"Mol. Biol. Rep."},{"issue":"10","key":"5074_CR40","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.3390\/ijms20102580","volume":"20","author":"M Pitrone","year":"2019","unstructured":"Pitrone, M. et al. Knockdown of NANOG reduces cell proliferation and induces G0\/G1 cell cycle arrest in human adipose stem cells. Int. J. Mol. Sci. 20(10), 2580 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"5074_CR41","doi-asserted-by":"publisher","first-page":"103336","DOI":"10.1016\/j.jddst.2022.103336","volume":"71","author":"S Javani","year":"2022","unstructured":"Javani, S. et al. Metronidazole conjugated bismuth sulfide nanoparticles for enhanced X-ray radiation therapy. J. Drug Deliv. Sci. Technol. 71, 103336 (2022).","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"5074_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15384047.2015.1121348","volume":"17","author":"N Gawlik-Rzemieniewska","year":"2016","unstructured":"Gawlik-Rzemieniewska, N. & Bednarek, I. The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells. Cancer Biol. Ther. 17(1), 1\u201310 (2016).","journal-title":"Cancer Biol. Ther."},{"key":"5074_CR43","doi-asserted-by":"publisher","first-page":"127369","DOI":"10.1016\/j.jtemb.2023.127369","volume":"83","author":"FJ Golrokh","year":"2024","unstructured":"Golrokh, F. J. et al. Apoptosis induction in colon cancer cells (SW480) by BiFe2O4@ Ag nanocomposite synthesized from Chlorella vulgaris extract and evaluation the expression of CASP8, BAX and BCL2 genes. J. Trace Elem. Med. Biol. 83, 127369 (2024).","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"1","key":"5074_CR44","doi-asserted-by":"publisher","first-page":"21245","DOI":"10.1038\/s41598-022-25360-6","volume":"12","author":"A Moradi","year":"2022","unstructured":"Moradi, A. et al. Synthesize of Bi2O3\/Gln-TSC nanoparticles and evaluation of their toxicity on prostate cancer cells and expression of CASP8, BAX, and Bcl-2 genes. Sci. Rep. 12(1), 21245 (2022).","journal-title":"Sci. Rep."},{"issue":"4","key":"5074_CR45","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2353\/ajpath.2008.080288","volume":"173","author":"MK Siu","year":"2008","unstructured":"Siu, M. K. et al. Overexpression of NANOG in gestational trophoblastic diseases: Effect on apoptosis, cell invasion, and clinical outcome. Am. J. Pathol. 173(4), 1165\u20131172 (2008).","journal-title":"Am. J. Pathol."},{"key":"5074_CR46","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1007\/s10620-012-2182-8","volume":"57","author":"F Xu","year":"2012","unstructured":"Xu, F. et al. Nanog: A potential biomarker for liver metastasis of colorectal cancer. Dig. Dis. Sci. 57, 2340\u20132346 (2012).","journal-title":"Dig. Dis. Sci."},{"key":"5074_CR47","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00432-012-1186-2","volume":"138","author":"A Borrull","year":"2012","unstructured":"Borrull, A. et al. Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells. J. Cancer Res. Clin. Oncol. 138, 1145\u20131154 (2012).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"8","key":"5074_CR48","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/stem.110","volume":"27","author":"P-Y Bourillot","year":"2009","unstructured":"Bourillot, P.-Y. et al. Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog. Stem Cells 27(8), 1760\u20131771 (2009).","journal-title":"Stem Cells"},{"issue":"30","key":"5074_CR49","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1038\/onc.2012.363","volume":"32","author":"MK Siu","year":"2013","unstructured":"Siu, M. K. et al. Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers. Oncogene 32(30), 3500\u20133509 (2013).","journal-title":"Oncogene"},{"key":"5074_CR50","doi-asserted-by":"publisher","first-page":"9941","DOI":"10.2147\/IJN.S228919","volume":"14","author":"NNT Sisin","year":"2019","unstructured":"Sisin, N. N. T. et al. Radiosensitization effects by bismuth oxide nanoparticles in combination with cisplatin for high dose rate brachytherapy. Int. J. Nanomed. 14, 9941\u20139954 (2019).","journal-title":"Int. J. Nanomed."},{"key":"5074_CR51","doi-asserted-by":"publisher","first-page":"7805","DOI":"10.2147\/IJN.S269214","volume":"15","author":"NN Talik Sisin","year":"2020","unstructured":"Talik Sisin, N. N. et al. Synergetic influence of bismuth oxide nanoparticles, cisplatin and baicalein-rich fraction on reactive oxygen species generation and radiosensitization effects for clinical radiotherapy beams. Int. J. Nanomed. 15, 7805\u20137823 (2020).","journal-title":"Int. J. Nanomed."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05074-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05074-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05074-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:18:23Z","timestamp":1751422703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05074-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5074"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05074-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all individual participants included in the study. This study was approved by the Research Ethics Committees of Zanjan University of Medical Sciences, Zanjan, Iran (Ethical Code: IR.ZUMS.REC.1400.518). Moreover, all methods were performed in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"23131"}}